Essilor will be presenting the results from a clinical trial of its Stellest lens at this year’s congress of the World Society of Paediatric Ophthalmology and Strabismus (WSPOS), scheduled for Sept. 25. Drs. Damien Paillé, Guillaume Giraudet and Björn Drobe, from Essilor International’s research and development team, will be on ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.